Roswell Park Comprehensive Cancer Center

Last updated
Roswell Park Comprehensive Cancer Center
National Comprehensive Cancer Network
Roswell Park Comprehensive Cancer Center Logo.png
Roswell Park Cancer Institute, Buffalo, New York - 20191009.jpg
Roswell Park Comprehensive Cancer Center
Geography
Location Buffalo, New York, United States
Coordinates 42°53′50″N78°52′01″W / 42.897185°N 78.866852°W / 42.897185; -78.866852
Organization
Care system Medicare
Type Specialist
Affiliated university University at Buffalo, the State University of New York
Services
Standards NCI-designated Cancer Center
Beds133 (licensed)
Speciality Oncology, Teaching hospital
History
Former name(s)The Pathological Laboratory of the University of Buffalo (1898 - 1899)
The Gratwick Research Laboratory (1900 - 1911)
The State Institute for the Study of Malignant Disease (1912-1945)
Roswell Park Memorial Institute (1946 - 1991)
Roswell Park Cancer Institute (1992 - 2017)
Opened1898;126 years ago (1898)
Links
Website www.roswellpark.org
Lists Hospitals in New York State
Other links List of NYS Public Benefit Corporations

Roswell Park Comprehensive Cancer Center is a cancer research and treatment center located in Buffalo, New York. Founded by surgeon Roswell Park in 1898, the center was the first in the United States to specifically focus on cancer research. [1] [2] [3] The center is usually called Roswell Park in short. The center, which conducts clinical research on cancer as well as the development new drugs, provides advanced treatment for all forms of adult and pediatric cancer, and serves as a member of the National Comprehensive Cancer Network. Roswell Park Comprehensive Cancer Center is as of 2019, the only upstate New York facility to hold the National Cancer Institute designation of "comprehensive cancer center". [4]

Contents

The Roswell Park campus, spread out in 15 separate buildings of approximately two million square feet, occupies 28 acres (11 ha) on the 100-acre (40 ha) Buffalo Niagara Medical Campus (BNMC) in downtown Buffalo, and includes 1,500,000 square feet (140,000 m2) of space equally distributed between clinical programs and research/education functions. A separate hospital building, completed in 1998, houses a diagnostic and treatment center. The campus also includes a medical research complex as well as research and education focused spaces.

History

In 1898, the program that would later become the cancer center was established by Roswell Park, who was a professor of surgery at the University of Buffalo School of Medicine. [5] Park said that "Only through a deliberate well-planned, combined attack from various directions by means fitted for such work could real advances be made and further the relationship of laboratory work, clinical study and education must be closely associated." [5]

Research started in three rooms in the University of Buffalo School of Medicine but not long thereafter, it outgrew the rooms. Seeing the importance of dedicated cancer research, select Buffalo citizens donated funds to purchase land and construct a new building. The largest contributor was Mrs. William Gratwick (wife of William H. Gratwick, the founder of Gratwick, Smith & Fryer Lumber Co.), who donated $25,000. The Gratwick Research Laboratory of the University of Buffalo was constructed in 1901 and was located at High and Elm streets. [6]

Park wrote books, gave lectures, and was the administrator at the cancer research center. In 1904, Park stepped down and Harvey R. Gaylord took over as the center's second director. Park remained as the chairman of the board of trustees. [7]

In coming decades the center was renamed the Roswell Park Cancer Institute, a name it retained for decades until 2018, when its current name was implemented. The Roswell Park Cancer Institute was usually called Roswell Park or RPCI for short.

Notable facts

Discoveries and advancements in cancer care

Discovery of how the human body converts glucose to glycogen

Gerty Cori and Carl Cori jointly won the 1947 Nobel Prize in Physiology or Medicine for their discovery of the way in which the body converts glucose to glycogen. Gerty Theresa Radnitz Cori (1896-1957) and Carl Ferdinand Cori - restoration1.jpg
Gerty Cori and Carl Cori jointly won the 1947 Nobel Prize in Physiology or Medicine for their discovery of the way in which the body converts glucose to glycogen.

Drs. Gerty and Carl Cori jointly won the 1947 Nobel Prize in Physiology or Medicine, "for their discovery of the course of the catalytic conversion of glycogen." [13] Their research leading to the discovery began during their tenure at Roswell Park (then called the New York State Institute for the Study of Malignant Diseases), from 1922 to 1931. [14]

Alternative breast cancer treatments

Thomas Dao (1921–2009), served as director of the breast surgery department from 1957 to 1988, where he developed breast cancer treatment alternatives. [15]

Development of photodynamic therapy

In 1975, Thomas Dougherty successfully treated preclinical models of cancer using photodynamic therapy (PDT) techniques for the first time. [16] [17] In 1978, he conducted the first PDT clinical trial. [18] [19] Today, PDT is an FDA-approved method for treating specific kinds of cancer, and is used around the world.

Discovery of PSA

Research resulting in the discovery of the prostate-specific antigen (PSA) was led by T. Ming Chu in the 1970s. [20] His team subsequently developed a way to detect the PSA protein in blood as a simple diagnostic test. [21] Since its FDA approvals in 1986 and 1994, an estimated one billion PSA tests have been given.

Research on 5-fluorouracil + leucovorin

Biochemist Marie Hakala, PhD [22] [23] first observed that 5-fluorouracil becomes more effective in treating cancer cells when calcium leucovorin is added. [24] [25] This discovery paved the way for the development of 5-FU + leucovorin therapy, which was for many years the gold standard of chemotherapy for colorectal cancer.

Research on SurVaxM

SurVaxM, a cancer immunotherapy vaccine, was awarded orphan drug status by the United States Food and Drug Administration in 2017. A phase II clinical trial of SurVaxM has shown that the vaccine, when combined with standard therapy, is more effective than standard therapies alone. [26]

Organization


Education

Roswell Park offers both Master's and PhD programs in Cancer Sciences. [27] These programs are offered in collaboration with the University at Buffalo Jacobs School of Medicine. [28]

Reputation

Roswell Park Comprehensive Cancer Center has received numerous accolades for the quality of healthcare provided.

Accreditation

Patient care

Scott Bieler Clinical Sciences Center Scott Bieler Clinical Sciences Center, Buffalo, New York - 20200507.jpg
Scott Bieler Clinical Sciences Center

Roswell Park provides comprehensive care for a wide range of cancers. [46]

Specialized treatments

Roswell Park offers specialized treatments, services and therapies to treat cancer, as well as services to support patients undergoing cancer treatment. [47] [48]

Collaborations

CIMAvax

Roswell Park was the first American institution to receive FDA permission to conduct clinical trials of CIMAvax, a Cuban medical therapy developed by Centro de Immunologica Molecular, La Habana, Cuba. [49] [50]

Ovarian Cancer SPORE

The Ovarian Cancer SPORE is a collaboration between Roswell Park and University of Pittsburgh Cancer Institute (UPCI). The SPORE project includes multiple research projects, core supportive structures, and career development programs. [51]

Cancer Registries

Stacey Scott Lung Cancer Registry

Together with the British Columbia Cancer Agency, Vancouver, Canada and Vrije Universiteit, Amsterdam, the Netherlands, Roswell Park manages the Stacey Scott Lung Cancer Registry. [52]

Familial Ovarian Cancer Registry

Founded in 1990 by Steven Piver, the Familial Ovarian Cancer Registry houses information relating to family history and lifestyle of patients and families with histories of ovarian cancer. [53] [54]

Research and training collaborations

Roswell Park collaborates with institutions around the world to strengthen cancer training and research programs. [55]

See also

Related Research Articles

A radiation oncologist is a specialist physician who uses ionizing radiation in the treatment of cancer. Radiation oncology is one of the three primary specialties, the other two being surgical and medical oncology, involved in the treatment of cancer. Radiation can be given as a curative modality, either alone or in combination with surgery and/or chemotherapy. It may also be used palliatively, to relieve symptoms in patients with incurable cancers. A radiation oncologist may also use radiation to treat some benign diseases, including benign tumors. In some countries, radiotherapy and chemotherapy are controlled by a single oncologist who is a "clinical oncologist". Radiation oncologists work closely with other physicians such as surgical oncologists, interventional radiologists, internal medicine subspecialists, and medical oncologists, as well as medical physicists and technicians as part of the multi-disciplinary cancer team. Radiation oncologists undergo four years of oncology-specific training whereas oncologists who deliver chemotherapy have two years of additional training in cancer care during fellowship after internal medicine residency in the United States.

<span class="mw-page-title-main">University of Texas Southwestern Medical Center</span> Public academic health science center in Dallas, Texas

The University of Texas Southwestern Medical Center is a public academic health science center in Dallas, Texas. With approximately 23,000 employees, more than 3,000 full-time faculty, and nearly 4 million outpatient visits per year, UT Southwestern is the largest medical school in the University of Texas System and the State of Texas.

<span class="mw-page-title-main">MD Anderson Cancer Center</span> Hospital in Texas, United States of America

The University of Texas MD Anderson Cancer Center is a comprehensive cancer center in Houston, Texas. It is the largest cancer center in the world and one of the original three NCI-designated comprehensive cancer centers in the country. It is both a degree-granting academic institution and a cancer treatment and research center located within Texas Medical Center (TMC), Houston, the largest medical center and life sciences destination in the world. MD Anderson Cancer Center has consistently ranked #1 among the best hospitals for cancer care and research in the U.S. and worldwide, and it has held the #1 position 20 times in the last 23 years in U.S. News & World Report's Best Hospitals rankings for cancer care. As of 2023, MD Anderson Cancer Center is home to the highest number of cancer clinical trials in the world and has received more NCI-funded projects than any other U.S. institute. For 2024, Newsweek placed MD Anderson at #1 in their annual list of the World's Best Specialized Hospitals in oncology.

<span class="mw-page-title-main">Targeted therapy</span> Type of therapy

Targeted therapy or molecularly targeted therapy is one of the major modalities of medical treatment (pharmacotherapy) for cancer, others being hormonal therapy and cytotoxic chemotherapy. As a form of molecular medicine, targeted therapy blocks the growth of cancer cells by interfering with specific targeted molecules needed for carcinogenesis and tumor growth, rather than by simply interfering with all rapidly dividing cells. Because most agents for targeted therapy are biopharmaceuticals, the term biologic therapy is sometimes synonymous with targeted therapy when used in the context of cancer therapy. However, the modalities can be combined; antibody-drug conjugates combine biologic and cytotoxic mechanisms into one targeted therapy.

James Larue Mohler is a urologist at Roswell Park. Mohler joined Roswell Park in 2003 as Chair of Urology and Leader of the Prostate Program. He became the associate director and Senior Vice President for Translational Research. He is Chair Emeritus, Urology, and Chief, Inter-Institutional Academics, and Professor of Oncology at Roswell Park Comprehensive Cancer Center, and adjunct professor of Urology and Member of UNC-Lineberger Comprehensive Cancer Center at University of North Carolina.

<span class="mw-page-title-main">Cancer and Leukemia Group B</span> U.S. research cooperative group

Cancer and Leukemia Group B is a cancer research cooperative group in the United States.

Spartanburg Regional Healthcare System(SRHS) is one of South Carolina's largest healthcare systems. SRHS draws patients primarily from the areas of Spartanburg, Cherokee, Union, and Greenville counties (all located in the Piedmont region of South Carolina), as well as Rutherford and Polk counties (located in western North Carolina). Spartanburg General Hospital was organized under the authority of the South Carolina General Assembly in 1917. It officially became the Spartanburg Regional Health Services District, Inc., a political subdivision of the State of South Carolina, by the charter granted by the Secretary of State of South Carolina on May 1, 1995.

The Society for Immunotherapy of Cancer (SITC), previously known as the International Society for Biological Therapy of Cancer (iSBTc), is a professional society of scientists, academicians, researchers, clinicians, government representatives, and industry leaders from around the world dedicated to improving outcomes in patients with cancer by advancing the science and application of cancer immunotherapy. Currently, SITC has more than 2,400 members, representing 22 medical specialties from 42 countries around the world, who are engaged in the research and treatment of cancer.

<span class="mw-page-title-main">NYU Langone Health</span> Hospital in New York, United States

NYU Langone Health is an academic medical center located in New York City, New York, United States. The health system consists of the NYU Grossman School of Medicine and NYU Grossman Long Island School of Medicine, both part of New York University (NYU), and more than 300 locations throughout the New York City Region and Florida, including six inpatient facilities: Tisch Hospital; Kimmel Pavilion; NYU Langone Orthopedic Hospital; Hassenfeld Children's Hospital; NYU Langone Hospital – Brooklyn; and NYU Langone Hospital – Long Island. It is also home to Rusk Rehabilitation. NYU Langone Health is one of the largest healthcare systems in the Northeast, with more than 49,000 employees.

<span class="mw-page-title-main">Saint Thomas - Rutherford Hospital</span> Hospital in Tennessee, United States

Saint Thomas Rutherford Hospital, formerly Middle Tennessee Medical Center, is a 286-bed private, not-for-profit hospital located in Murfreesboro, Tennessee, United States. Saint Thomas Rutherford Hospital is a member of Ascension Saint Thomas.

<span class="mw-page-title-main">Roswell Park</span> American surgeon

Roswell Park was an American physician and cancer researcher, best known for starting Gratwick Research Laboratory in 1898, which is now known as Roswell Park Comprehensive Cancer Center.

<span class="mw-page-title-main">University of Florida College of Medicine-Jacksonville</span> Medical school of the University of Florida in Jacksonville

The University of Florida College of Medicine – Jacksonville is the largest of the three University of Florida Health Science Center Jacksonville colleges — medicine, nursing and pharmacy. The college's 16 clinical science departments house more than 440 faculty members and 380 residents and fellows. The college offers 34 accredited graduate medical education programs and 10 non-standard programs.

Gerold Bepler is the former president and chief executive officer of the Barbara Ann Karmanos Cancer Institute in Detroit, Michigan.

CimaVax-EGF is a vaccine used to treat cancer, specifically non-small-cell lung carcinoma (NSCLC). CIMAvax-EGF is composed of recombinant human epidermal growth factor (EGF) conjugated to a protein carrier.

<span class="mw-page-title-main">King Fahad Specialist Hospital Dammam</span> Hospital in Eastern Region, Saudi Arabia

King Fahad Specialist Hospital-Dammam (KFSHD) is a district general hospital in the Eastern region of Saudi Arabia.

Mikhail Blagosklonny was a scientist who studied cancer and aging. He died in October 2024. He was an adjunct faculty member at Roswell Park Comprehensive Cancer Center in Buffalo, New York.

Michael A. Caligiuri is an American physician scientist focused on oncology and immunology. He is currently the president of the City of Hope National Medical Center and the Deana and Steve Campbell Physician-in-Chief Distinguished Chair. He was elected president of the American Association for Cancer Research, the world's largest cancer research organization, for 2017–2018. He was previously the CEO of the James Cancer Hospital (2008-2017), Director of the Comprehensive Cancer Center (2003-2017), and Director of the Division of Hematology-Oncology (2000-2008) at the Ohio State University. He was elected to the United States National Academy of Medicine in 2018.

<span class="mw-page-title-main">Bhagwan Mahaveer Cancer Hospital and Research Centre</span> Hospital in Rajasthan, India

The Bhagwan Mahaveer Cancer Hospital and Research Centre (BMCHRC) is located in Jawahar Lal Nehru Marg, Bajaj Nagar, Jaipur, Rajasthan. It is also popularly known as BMCHRC. The hospital is NABH and NABL accredited super speciality cancer treatment centre. The hospital is following international protocol for cancer treatment managed by K.G. Kothari Memorial Trust. The centre is committed to providing comprehensive care along with prevention and research in cancer.

Adekunle O. Odunsi is an American gynecologic oncologist. In 2021, Odunsi became the director of the University of Chicago Comprehensive Cancer Center.

Beth Young Karlan is an American gynecologic oncologist. In 2008, she was named editor-in-chief of the medical journals Gynecologic Oncology and Gynecologic Oncology Reports. In 2012, Karlan was appointed by the White House to serve on the National Cancer Advisory Board, and in 2015, she was elected to the National Academy of Medicine.

References

  1. Rusch, Harold P (1985). "Beginnings of Cancer Research Centers in the United States". Journal of the National Cancer Institute . 74 (2): 391–403. doi:10.1093/jnci/74.2.391. PMID   3883036. The first center in the United States devoted specifically for research on cancer was founded by Dr. Roswell Park in 1898. Dr. Park, a professor of surgery at the University of Buffalo (Buffalo, NY), with Mr. Edward Butler, publisher of the Buffalo Evening News, in 1897 persuaded the legislators of New York State to appropriate $7,500 for cancer research.
  2. "Roswell Park celebrates 120 years with time capsule". WGRZ . April 25, 2018. Retrieved May 10, 2021.
  3. "1898-1950". Roswell Park Comprehensive Cancer Center. Retrieved May 10, 2021.
  4. "Roswell Park Comprehensive Cancer Center". National Cancer Institute. 2019. Retrieved May 11, 2021.
  5. 1 2 Mirand, Edwin A (1998). Legacy And History Of Roswell Park Cancer Institute, 1898-1998. Virginia Beach, VA: The Donning Company. p. 9. ISBN   9781578642816.
  6. Mirand, Edwin A (1998). Legacy And History Of Roswell Park Cancer Institute, 1898-1998. Virginia Beach, VA: The Donning Company. p. 16. ISBN   9781578642816.
  7. Mirand, Edwin A (1998). Legacy And History Of Roswell Park Cancer Institute, 1898-1998. Virginia Beach, VA: The Donning Company. p. 21. ISBN   9781578642816.
  8. "1898-1950". Roswell Park Comprehensive Cancer Center. Retrieved 2021-05-10.
  9. "Nobel Prize awarded women". The Nobel Prize . Nobel Prize Outreach AB. Retrieved May 12, 2021.
  10. "Roswell Park Announces Candace S. Johnson, PhD, as Institute's 15th President & CEO". Roswell Park Comprehensive Cancer Center. Retrieved 2021-05-10.
  11. "Bladder Cancer Surgery". Roswell Park Comprehensive Cancer Center. Retrieved May 13, 2021.
  12. "Roswell Park Creates Center of Excellence for Adolescents and Young Adults with Cancer". Roswell Park Comprehensive Cancer Center. February 11, 2011. Retrieved May 13, 2021.
  13. "The Nobel Prize in Physiology or Medicine 1947". The Nobel Prize . Nobel Prize Outreach AB. Retrieved May 12, 2021.
  14. "Gerty Cori - Biographical". The Nobel Prize . Nobel Prize Outreach AB. Retrieved May 10, 2021.
  15. Hevesi, Dennis (July 25, 2009). "Dr. Thomas Dao, Expert on Treatment of Breast Cancer, Dies at 88" . Health. The New York Times . Retrieved July 26, 2009.
  16. Dougherty, Thomas; Grindey, G; Fiel, R; Weishaupt, K; Boyle, D (1955). "Photoradiation therapy. II. Cure of animal tumors with hematoporphyrin and light". Journal of the National Cancer Institute . 55 (1): 115–121. doi:10.1093/jnci/55.1.115. PMID   1159805.
  17. "Remembering Dr. Dougherty, Chief Emeritus, PDT Center". American Society for Photobiology . Retrieved May 11, 2021.
  18. Dougherty, Thomas; Kaufman, Jerome; Goldfarb, Abraham; Weishaupt, Kenneth; Boyle, Donn; Mittleman, Arnold (1987). "Photoradiation Therapy for the Treatment of Malignant Tumors" (PDF). Cancer Research . 38 (8): 2628–2635. PMID   667856 via PubMed.
  19. "1970s & 1980s". Roswell Park Comprehensive Cancer Center. Retrieved May 11, 2021.
  20. "From the History Books: Blood Test Gives Urologists a New Way to Detect Prostate Cancer". The William P. Didusch Center for Urologic History. American Urological Association . Retrieved May 11, 2021. In 1979, Chu's colleagues, led by M.C. Wang, characterized and purified the antigen, and in 1980, Lawrence D. Papsidero and fellow scientists confirmed its presence in the blood of prostate cancer patients. Amidst that activity, Chu introduced the PSA test, a screen that picks up early prostate cancer by detecting elevated levels of PSA in the blood.
  21. Roswell Park Comprehensive Cancer Center (March 30, 2021). "T. Ming Chu: The Man Behind the PSA Test". Cancer History Project. Retrieved May 11, 2021.
  22. "Marie T. Hakala-Zakrzewski". The Buffalo News . Legacy.com. Retrieved May 12, 2021.
  23. "In Memoriam: Marie Hakala-Zakrzewski". American Association for Cancer Research . Retrieved May 12, 2021.
  24. Evans, Mark; Laskin, Jeffrey; Hakala, Marie (September 1981). "Effects of Excess Folates and Deoxyinosine on the Activity and Site of Action of 5-Fluorouracil". Cancer Research . 41 (9): 3288–3295. PMID   6973389 via PubMed.
  25. Berger, S; Hakala, Marie (May 1990). "Calcium leucovorin and 5-fluorouridine cytotoxicity". Journal of the South Carolina Medical Association. 86 (5): 284–289. PMID   2242115 via PubMed.
  26. "SurVaxM with standard therapy in newly diagnosed glioblastoma: Phase II trial update". ASCO. Retrieved January 23, 2024.
  27. "Master's & PhD Degrees in Cancer Sciences". Roswell Park Comprehensive Cancer Center. Retrieved January 23, 2024.
  28. "Cancer Sciences PhD, Roswell Park Graduate Division". University at Buffalo. Retrieved January 23, 2024.
  29. "Roswell Park Ranks 14th on List of Nation's Best Hospitals for Cancer". Roswell Park Comprehensive Cancer Center. 30 July 2019. Retrieved June 22, 2020.
  30. "Roswell Park says ranking on national list meaningful to doctors, patients". The Buffalo News. July 30, 2019. Retrieved June 22, 2020.
  31. "Roswell Park Comprehensive Cancer Center". U.S. News & World Report . Retrieved May 10, 2021.
  32. "Roswell Park Comprehensive Cancer Center Colon Cancer Surgery Scorecard". U.S. News & World Report . Retrieved May 11, 2021.
  33. "Roswell Park Comprehensive Cancer Center Lung Cancer Surgery Scorecard". U.S News & World Report . Retrieved May 11, 2021.
  34. "Blue Distinction Centers for Cancer Care - Directory of Providers" (PDF). BlueCross BlueShield (PDF). Blue Cross Blue Shield Association. January 27, 2021. p. 15. Retrieved May 11, 2021.
  35. "Blue Distinction Centers for Transplants - Directory of Providers" (PDF). BlueCross BlueShield (PDF). Blue Cross Blue Shield Association. April 14, 2021. p. 17. Retrieved May 11, 2021.
  36. "Blue Distinction Centers for Cellular Immunotherapy - Directory of Providers" (PDF). BlueCross BlueShield (PDF). Blue Cross Blue Shield Association. March 31, 2021. p. 3. Retrieved May 11, 2021.
  37. "Health Systems Recognized by IHI". Institute for Healthcare Improvement . 2021. Retrieved May 11, 2021.
  38. "Accredited Facility Search". American College of Radiology (XLS). Retrieved May 12, 2021.
  39. "Cancer Centers of Excellence Network". Optum . 2021. Retrieved May 12, 2021.
  40. "Screening Centers". GO2 Foundation For Lung Cancer. Retrieved May 12, 2021.
  41. "QOPI Certified Practices". American Society of Clinical Oncology and Association for Clinical Oncology . Retrieved May 12, 2021.
  42. "Roswell Park Comprehensive Cancer Center". American College of Surgeons. Retrieved 2021-05-10.
  43. "Roswell Park Comprehensive Cancer Center". National Cancer Institute. Retrieved 2021-05-10.
  44. "Roswell Park Comprehensive Cancer Center". National Comprehensive Cancer Network. Retrieved 2021-05-10.
  45. "Be The Match - Roswell Park Comprehensive Cancer Center". Be The Match. National Marrow Donor Program. Retrieved 2021-05-10.
  46. "Cancer Types". Roswell Park Comprehensive Cancer Center. Retrieved May 11, 2021.
  47. "Treatments at Roswell Park". Roswell Park Comprehensive Cancer Center. Retrieved May 11, 2021.
  48. "Support". Roswell Park Comprehensive Cancer Center. Retrieved May 11, 2021.
  49. "Gov. Cuomo Announces Landmark Roswell Park Study Bringing Cuban Lung Cancer Vaccine to U.S. Patients, and Approval of Historic U.S. Government License Authorizing U.S.–Cuba Commercial Partnership to Fast-Track Biotech Development". Roswell Park Comprehensive Cancer Center. October 26, 2016. Retrieved May 10, 2021.
  50. Kroll, David (November 26, 2016). "Fidel Castro-Supported Lung Cancer Vaccine To Be Tested In U.S. Clinical Trials". Forbes . Retrieved May 10, 2021.
  51. "Roswell Park - UPCI Ovarian Cancer SPORE Overview". Roswell Park Comprehensive Cancer Center. Retrieved May 13, 2021.
  52. "Stacey Scott Lung Cancer Registry". Roswell Park Comprehensive Cancer Center. Retrieved May 12, 2021.
  53. "About The Familial Ovarian Cancer Registry". Roswell Park Comprehensive Cancer Center. Retrieved May 13, 2021.
  54. "What is the Registry?". Roswell Park Comprehensive Cancer Center. Retrieved May 13, 2021.
  55. "International Collaborations". Roswell Park Comprehensive Cancer Center. Retrieved May 12, 2021.
  56. "International Team of Researchers Reports Promising Results in Study of Pediatric Neuroblastoma". Roswell Park Comprehensive Cancer Center. November 6, 2015. Retrieved May 13, 2021.
  57. "Roswell Park Establishes Partnership with Jagiellonian University in Krakow, Poland". Roswell Park Comprehensive Cancer Center. November 15, 2018. Retrieved May 13, 2021.
  58. "Roswell Park Comprehensive Cancer Center to Train Clinical Staff from Saudi Hospital in Cancer Care". Roswell Park Comprehensive Cancer Center. November 17, 2010. Retrieved May 12, 2021.
  59. "Intercontinental Oncology Partnership Brings Access to Specialized Cancer Care to Nigeria". Roswell Park Comprehensive Cancer Center. June 30, 2015. Retrieved May 12, 2021.
  60. "On Solidarity Trip to Israel, Governor Cuomo Announces Establishment of Joint Program Uniting U.S. and Israeli Cancer Experts in Effort to Research and Develop New Cancer Therapies and Precision Diagnostic Tools". Roswell Park Comprehensive Cancer Center. July 2, 2019. Retrieved May 13, 2021.
  61. "Roswell Park Designated Scientific Lead for Ongoing Population Assessment of Tobacco and Health (PATH) Study". Roswell Park Comprehensive Cancer Center. April 4, 2021. Retrieved May 13, 2021.